MYXOREN, lyophilisate and solvent for parenteral injection
Homepage Products Veterinary products MYXOREN, lyophilisate and solvent for parenteral injection
Live attenuated vaccine against myxomatosis.
type of preparative: | Vaccines |
---|---|
target species animals: | Rabbit |
Composition in 1 ml
Active substance |
Amount |
Method of administration |
Poxvirus myxomatosae attenuatum |
min. 103,3 TCID50 max. 105,8TCID50 |
s.c. (1 ml) |
Poxvirus myxomatosae attenuatum |
min. 102,6 TCID50 max. 105,1TCID50 |
i.d. (needleless- 0,1 ml) |
Poxvirus myxomatosae attenuatum |
min. 102,6 TCID50 max. 105,1TCID50 |
ear puncture (double injection) |
Aluminium hydroxide gel, sodium merthiolate, saline solution
Target species
Rabbits.
Indication
For active immunisation of rabbits against myxomatosis.
Maternal antibodies can interfere with the vaccine and therefore vaccination before
the 4th week of age is not recommended.
Route of administration and dosage
SC (subcutaneously) = 1 ml
ID (intradermally – needless) = 0.1 - 0.2 ml
Auricular (ear puncture) = 0.2 ml
Primary vaccination since the age of 10 weeks.
In myxomatosis high infection conditions, rabbits can be vaccinated since the age of 4 weeks and revaccination at the age of 10 weeks.
In breeding animals’ booster vaccination is required every 6 months.
Storage
Store in a dark and dry place at the temperature between 2 °C - 8 °C.
Withdrawal period
None.
Shelf life
24 months.
Package
1 x 10, 1 x 20, 5 x 10, 5 x 20 subcutaneous doses.
1 x 40, 1 x 80, 1 x 50, 1 x 100, 5 x 40, 5 x 80, 5 x 50, 5 x 100 needless dose.
1 x 50, 1 x 100, 5 x 50, 5 x 100 doses applied with double needle.